OcellO is a contract research organisation which offers R & D outsourcing to pharmaceutical companies for in vitro compound testing using human tissue models. OcellO uses a proprietary best-in-class high throughput 3D cell culture-based screening platform. This technology allows high content imaging to be applied to compound screening, lead and target validation, providing rich information about compound properties.